DAVITA INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
DAVITA INC. (DVA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $22.90 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2021-02-12
- DAVITA INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $22.90M, a 6.75% increase from fiscal 2019.
- DAVITA INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $21.45M, a 133.37% increase from fiscal 2018.
- DAVITA INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $9.19M, a 74.55% increase from fiscal 2017.
- DAVITA INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $5.27M, a 193.37% increase from fiscal 2016.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2020-12-31 | $22.90M 10-K · filed 2021-02-12 |
| 2019-12-31 | $21.45M 10-K · filed 2020-02-21 |
| 2018-12-31 | $9.19M 10-K · filed 2019-02-22 |
| 2017-12-31 | $5.27M 10-K · filed 2018-02-23 |
| 2016-12-31 | $1.79M 10-K · filed 2017-02-24 |
| 2015-12-31 | $29.03M 10-K · filed 2016-02-26 |
| 2014-12-31 | $12.81M 10-K · filed 2015-02-26 |
| 2013-12-31 | $1.27M 10-K · filed 2014-02-21 |
| 2012-12-31 | $2.14M 10-K · filed 2013-03-01 |
| 2011-12-31 | $4.64M 8-K · filed 2012-07-06 |
| 2010-12-31 | $3.19M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |